MATERAZZI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 26.207
AS - Asia 11.458
EU - Europa 10.894
SA - Sud America 1.643
Continente sconosciuto - Info sul continente non disponibili 707
AF - Africa 559
OC - Oceania 15
Totale 51.483
Nazione #
US - Stati Uniti d'America 25.448
IT - Italia 4.620
SG - Singapore 3.803
CN - Cina 3.142
HK - Hong Kong 1.841
DE - Germania 1.435
BR - Brasile 1.368
SE - Svezia 1.349
VN - Vietnam 999
BG - Bulgaria 661
GB - Regno Unito 572
CA - Canada 533
FR - Francia 480
TR - Turchia 448
FI - Finlandia 444
RU - Federazione Russa 339
IN - India 259
UA - Ucraina 223
AT - Austria 221
CI - Costa d'Avorio 211
JP - Giappone 198
NL - Olanda 153
KR - Corea 149
BD - Bangladesh 121
SN - Senegal 103
MX - Messico 96
CH - Svizzera 91
IQ - Iraq 85
AR - Argentina 72
ZA - Sudafrica 59
PK - Pakistan 56
MA - Marocco 54
ES - Italia 51
ID - Indonesia 50
PL - Polonia 50
SA - Arabia Saudita 50
CO - Colombia 44
EC - Ecuador 41
VE - Venezuela 41
BE - Belgio 39
NG - Nigeria 37
UZ - Uzbekistan 37
JM - Giamaica 28
CL - Cile 25
CZ - Repubblica Ceca 23
KE - Kenya 23
CR - Costa Rica 20
JO - Giordania 20
PH - Filippine 19
IL - Israele 18
MY - Malesia 18
IE - Irlanda 17
IR - Iran 17
LT - Lituania 17
NP - Nepal 17
PY - Paraguay 17
TN - Tunisia 15
DZ - Algeria 14
EE - Estonia 14
EG - Egitto 14
HN - Honduras 14
HU - Ungheria 13
NI - Nicaragua 12
PE - Perù 12
PT - Portogallo 11
AL - Albania 10
AU - Australia 10
BO - Bolivia 10
GR - Grecia 10
LB - Libano 10
PA - Panama 10
RO - Romania 10
TW - Taiwan 10
UY - Uruguay 10
AZ - Azerbaigian 9
KG - Kirghizistan 9
OM - Oman 9
PS - Palestinian Territory 9
RS - Serbia 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
BB - Barbados 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
BY - Bielorussia 6
DK - Danimarca 6
SV - El Salvador 6
BJ - Benin 5
ET - Etiopia 5
LK - Sri Lanka 5
QA - Qatar 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
BH - Bahrain 4
GT - Guatemala 4
MK - Macedonia 4
PR - Porto Rico 4
AO - Angola 3
EU - Europa 3
GA - Gabon 3
Totale 50.720
Città #
Ashburn 2.784
Dallas 2.315
Singapore 2.136
Hong Kong 1.803
Woodbridge 1.786
Fairfield 1.753
San Jose 1.586
Houston 1.289
Chandler 1.280
Ann Arbor 1.221
Santa Clara 1.127
Milan 792
Seattle 721
Shanghai 690
Sofia 648
Beijing 622
Wilmington 608
Cambridge 606
New York 549
Council Bluffs 514
Los Angeles 412
Serra 403
Boardman 377
Ottawa 336
Princeton 306
Lawrence 266
Ho Chi Minh City 264
Izmir 256
Florence 253
Jacksonville 253
Rome 250
Lauterbourg 244
Munich 241
Medford 228
Abidjan 211
Hefei 208
Nanjing 200
Vienna 193
Pisa 188
Tokyo 180
Hanoi 175
London 158
Buffalo 153
Des Moines 152
Frankfurt am Main 147
São Paulo 140
Seoul 139
Helsinki 136
Dong Ket 132
Istanbul 124
Redondo Beach 122
Dearborn 111
San Diego 106
Dakar 103
Turku 103
Columbus 84
Naples 74
Bern 72
Piscataway 66
Bremen 65
Nanchang 64
Ogden 60
The Dalles 59
Chicago 58
Lancaster 57
Atlanta 56
Redwood City 56
Kunming 54
Montreal 54
Phoenix 50
Bologna 49
Toronto 49
Orem 48
Jüchen 47
Hebei 44
Paris 44
Changsha 43
Düsseldorf 43
Boulder 42
Washington 41
Lucca 40
Rio de Janeiro 40
San Francisco 40
Haiphong 39
Nuremberg 39
Shenyang 39
Brooklyn 38
Chennai 38
Guangzhou 38
Falls Church 36
Baghdad 35
Belo Horizonte 35
Brussels 35
Warsaw 35
Amsterdam 34
Denver 34
Lagos 34
Cascina 33
Fuzhou 33
Tashkent 33
Totale 34.207
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.179
Fistole del seno piriforme in un adolescente 962
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 355
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 327
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 282
Acquired Carotid-Jugular Fistula: Its Changing History and Management 281
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 275
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 261
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 258
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 256
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 251
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 245
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 241
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 236
Minimally invasive video-assisted thyroidectomy (MIVAT) from A to Z 234
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 233
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 233
Sorafenib in the treatment of thyroid cancer 232
Aggressive thyroid cancer: targeted therapy with sorafenib 231
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 231
Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. 229
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 227
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 225
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 223
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 223
Sorafenib and Thyroid Cancer 222
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 220
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 220
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 219
Energy-based devices in thyroid surgery-an overview 217
A pandemic recap: lessons we have learned 216
Evaluation of a new ultrasonic device in thyroid surgery: comparative randomized study 213
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 212
Minimally invasive video-assisted thyroidectomy (MIVAT) 212
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 212
Minimally invasive thyroidectomy in the treatment of well differentiated thyroid cancers: indications and limits 209
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 207
The effect of robot-assisted transaxillary thyroidectomy (RATT) on body image is better than the conventional approach with cervicotomy: a preliminary report 205
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 204
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 203
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 202
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 201
Modified lateral neck lymphadenectomy: prospective randomized study comparing harmonic scalpel with clamp-and-tie technique 199
Selective use of vandetanib in the treatment of thyroid cancer 198
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 198
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 198
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 196
Cabozantinib in Thyroid Cancer 196
Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules: An Efficient and Safe Alternative to Surgery 193
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 193
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 192
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 192
Video-assisted thyroidectomy: indications and results 191
The extent of surgery in thyroglossal cyst carcinoma 191
Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer 189
Persistent primary hyperparathyroidism caused by an ectopic adenoma in the piriform sinus: case report and review of the literature 189
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 189
Silent Pheocromocytoma presenting as tako-Tsubo syndrom during anesthesiological stress. 188
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 186
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 185
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 185
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 184
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 183
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 183
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 182
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 181
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 181
Novel treatments for anaplastic thyroid carcinoma 181
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 181
Conservative management of a tracheal leakage occurring 40 days after robotic thyroidectomy 180
Track Recurrence after Robotic Transaxillary Thyroidectomy: A Case Report Highlighting the Importance of Controlled Surgical Indications and Addressing Unprecedented Complications 180
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. 179
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 179
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 178
Impact of energy-based devices in pediatric thyroid surgery 178
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 177
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases 176
Tailored surgery according to molecular analysis in differentiated thyroid carcinomas 176
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management 176
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 175
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 175
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 175
Minimally Invasive Videoassisted thyroidectomy 174
Factors associated with postoperative hypocalcemia following thyroidectomy in childhood 174
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 173
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 172
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 172
Peduncolated adenomas with invasive carcinoma removed endoscopically . Is it necessary surgical treatment? 171
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 171
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 171
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 171
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 170
ANTIGENIC EXPRESSION OF M2 PYRUVATE-KINASE IN COLON RECTAL CANCER.PRELIMINARY RESULTS OF AN IMMUNOISTCHEMICAL STUDY 170
Postoperative Pain Evaluation After Robotic Transaxillary Thyroidectomy Versus Conventional Thyroidectomy: A Prospective Study 170
Prevention and management of bleeding in thyroid surgery 170
Endoscopic Parathyroidectomy 169
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 169
Impact of harmonic scalpel on operative time during video-assisted thyroidectomy 169
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 169
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 168
Totale 22.005
Categoria #
all - tutte 149.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.823 0 0 101 184 557 440 73 137 169 98 180 884
2022/20234.191 484 546 286 348 447 500 61 337 741 48 318 75
2023/20243.437 357 317 388 296 476 561 192 135 107 86 194 328
2024/202510.234 135 384 155 597 889 1.049 861 567 1.083 1.326 1.113 2.075
2025/202613.577 878 1.740 2.024 1.103 1.223 1.144 2.000 575 644 1.345 447 454
2026/20272.319 317 1.006 996 0 0 0 0 0 0 0 0 0
Totale 51.483